AstraZeneca blood pressure drug succeeds in late-stage trial

  • Posted on October 7, 2025
  • By Financial Times
  • 2 Views
AstraZeneca blood pressure drug succeeds in late-stage trial

Baxdrostat meets goals for patients with resistant hypertension and may generate sales of $5bn a year
continue reading...

Author
Financial Times

You May Also Like